Schematic representation of different strategies targeting TGF-β signaling for liver fibrosis therapy. TGF-β signaling inhibitors hold important therapeutic potential for hepatic fibrosis. Although ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Hepta, a biotechnology company using transformer-based AI to decode the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, ...
A recent review highlights a promising therapeutic target for metabolic dysfunction–associated fatty liver disease (MAFLD) ...
Ferroptosis plays an essential role in chronic liver diseases, and cyclooxygenase-2 (COX-2) affects liver fibrosis through multiple mechanisms. However, research on COX-2 regulation of ferroptosis in ...
Scientists at the University of Science and Technology of China have identified a signaling chain that starts with gut ...
Researchers from The University of Osaka find that chronic liver congestion is linked to severe liver diseases through a specific signaling pathway in liver sinusoidal endothelial cells - key cells ...
Researchers at UC Berkeley have built a microfluidic organ-on-a-chip system that compresses roughly 40 years of human aging ...
The long-term stasis of blood in the liver, known as chronic liver congestion, can lead to a range of diseases, some of which are fatal. However, identifying how liver congestion causes these diseases ...
The Fibrosis-4 (FIB-4) index, computed from age, aspartate aminotrasfertase (AST) and alanine aminotransferase (ALT) levels, and platelet count, was originally developed in 832 pa ...